Kyowa Kirin Services Ltd

Active02360391 Private limited company
Incorporated
13 March 1989 (37 years)
Previously known as
Archimedes Development Limited (until 29 December 2017)
West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited (until 4 March 2005)
Danbiosyst UK Limited (until 4 March 1999)
Industry
Other research and experimental development on natural sciences and engineering (72190)
Directors
Owned by
Accounts type
Full
Region
Greater London
Address
1st Floor Sackville House
143-149 Fenchurch Street
London
EC3M 6BL

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
13 March 2027
Last conf. stmt
27 February 2026

Charges

Total
1
Outstanding
0
Part satisfied
0
Satisfied
1

Officers 4 active

Officer details are public data from the Companies House register.

Director · Appointed 1 June 2026
Also at Kyowa Kirin Pharmaceutical Development Limited, Kyowa Kirin International PLC, Archimedes Pharma UK Limited · more companies
British
Born August 1977 (49)
Director · Appointed 3 November 2025
Also at Kyowa Kirin International PLC
French
Born April 1973 (53)
Director · Appointed 22 April 2020
Also at Kyowa Kirin Pharmaceutical Development Limited, Archimedes Pharma UK Limited · more companies
Austrian
Born May 1970 (56)
Corporate Secretary · Appointed 17 February 2015
Also at Kyowa Kirin Pharmaceutical Development Limited, Kyowa Kirin Limited, Woodside Energy (N.A.) Ltd · more companies
Officer history (35 former)
1 June 2026
Resigned Aristidou, Antrinkos Andrew as Director
1 June 2026
Appointed Mochan, Lori Elizabeth as Director
3 November 2025
3 November 2025
Resigned Morgan, Jeremy Lewis as Director
1 August 2023
Resigned King, Alan Fernie as Director
22 February 2023
Appointed Morgan, Jeremy Lewis as Director
28 September 2020
Appointed Aristidou, Antrinkos Andrew as Director
22 April 2020
Resigned Watson, Allan Mark as Director
22 April 2020
Resigned Mclean, Andrew Firth as Director
22 April 2020
Appointed Reisinger, Roswitha, Dr as Director
22 April 2020
Appointed King, Alan Fernie as Director
31 March 2019
Resigned Stratford, Harry Thomas, Dr as Director
17 February 2015
Appointed Mcs Formations Limited as Corporate Secretary
5 August 2014
Appointed Watson, Allan Mark as Director
5 August 2014
Appointed Mclean, Andrew Firth as Director
5 August 2014
Resigned Rothwell, Nicholas Gordon as Director
5 August 2014
Appointed Stratford, Harry Thomas, Dr as Director
5 August 2014
Resigned Buchalter, Jeffrey H as Director
5 August 2014
Resigned Reinhart, Charles Augustine as Director
19 December 2013
Resigned Perelman, Michael Roger Sidney as Secretary
19 December 2013
Resigned Perelman, Michael Roger Sidney as Director
21 September 2012
Resigned Kanovsky, Stephen as Secretary
21 September 2012
Resigned Kanovsky, Stephen as Secretary
21 September 2012
Appointed Perelman, Michael Roger Sidney as Secretary
1 June 2012
Appointed Buchalter, Jeffrey H as Director
26 March 2012
Resigned Buchalter, Jeffrey H as Director
26 March 2012
Appointed Rothwell, Nicholas Gordon as Director
23 September 2011
Appointed Reinhart, Charles Augustine as Director
22 September 2011
Resigned Watts, Timothy William as Director
1 February 2011
Appointed Buchalter, Jeffrey H as Director
31 January 2011
Resigned Clark, Michael Leslie as Director
30 September 2010
Appointed Kanovsky, Stephen as Secretary
30 September 2010
Resigned Marchetti, Charles as Secretary
30 September 2010
Appointed Kanovsky, Stephen as Secretary
30 September 2010
Appointed Perelman, Michael Roger Sidney as Director
30 September 2010
Resigned Marchetti, Charles as Director
3 December 2009
Resigned De Souza, Richard Anthony as Director
1 October 2008
Appointed Watts, Timothy William as Director
17 February 2005
Appointed Marchetti, Charles as Secretary
17 February 2005
Appointed Marchetti, Charles as Director
17 February 2005
Appointed De Souza, Richard Anthony as Director
17 February 2005
Appointed Clark, Michael Leslie as Director
9 February 2005
Resigned Ellers, Steven A as Director
9 February 2005
Resigned Graver, Jane Louise as Secretary
9 February 2005
Resigned Morel, Donald Eugene as Director
9 February 2005
Resigned Littler, William as Director
31 December 2004
Resigned Morra, Bruce, Dr as Director
28 May 2003
Appointed Morra, Bruce, Dr as Director
31 March 2003
31 March 2003
Resigned Little, William G as Director
1 May 2002
Appointed Graver, Jane Louise as Secretary
1 May 2002
Resigned Littler, William as Secretary
29 October 1999
Appointed Littler, William as Secretary
29 October 1999
Appointed Littler, William as Director
29 October 1999
Resigned Dorsey, Jerry E as Director
29 October 1999
Resigned Fox, Christine Joy as Secretary
12 August 1999
Resigned Illum, Lisbeth, Professor as Director
16 October 1998
Appointed Little, William G as Director
16 October 1998
Appointed Ellers, Steven A as Director
15 October 1998
Resigned Gailey Iii, John Robert as Director
31 March 1998
Appointed Dorsey, Jerry E as Director
31 March 1998
Appointed Gailey Iii, John Robert as Director
18 March 1996
Appointed Fox, Christine Joy as Secretary
18 March 1996
Resigned Davis, Stanley Stewart, Professor as Secretary
1 August 1995
Resigned Farraj, Nidal, Dr as Director
20 September 1994
Appointed Morel, Donald Eugene as Director
20 September 1994
Resigned Transatlantic Capital Biosciences Limited as Corporate Director
19 March 1992
Resigned Dean, Gordon Douglas as Director
19 March 1992
Appointed Transatlantic Capital Biosciences Limited as Corporate Director
1 September 1991
Appointed Davis, Stanley Stewart, Professor as Director
2 August 1991
Appointed Dean, Gordon Douglas as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 30 November 2017
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. Sc198780
Former controllers (1)
30 November 2017
Ceased Archimedes Pharma Limited — Owns 75–100% of shares

Group structure 5 companies

Ownership group derived from the Companies House PSC register

Kyowa Kirin International PLC
Archimedes Pharma UK Limited Owns 75–100% of shares
Kyowa Kirin Pharmaceutical Development Limited Owns 75–100% of shares
Kyowa Kirin Services Ltd This company Owns 75–100% of shares
Kyowa Kirin Limited Owns 75–100% of shares

Filings 224

DateDescriptionMade Up ToPagesPDF
29 October 2026Full accounts31 December 2025
1 June 2026Termination of appointment of a director
1 June 2026Appointment of a director
5 March 2026Confirmation statement with no updates27 February 2026
6 November 2025Appointment of a director
Show all 224 filings

Some other companies at this address

1 & 2 Park Lane Limited
74 Wandsworth Bridge Road Limited
Aee Renewables UK 31 Limited
Ajw Technology Consulting Ltd
Alexis Fund Management LLP
Ali Jacobs Counselling and Psychotherapy Ltd

Other companies in this industry

Oxon
London
London
Derbyshire
Norwich
Kettering

By trade and location

New companies in London →

Explore the largest companies

Largest companies in London, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?